SCHEMBL30677064

SCHEMBL30677064

CC(C)(O)c1cc(C2CC2)n(-c2ccc(CNc3nc(Cl)ncc3N)cc2)n1

nearest known ligand 0.39

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CRACR2A Q9BSW2 15/20 0.39
▸ PDE10A Q9Y233 2/20 0.35
▸ ORAI1 Q96D31 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30677045 0.89 CRACR2A (0.48) CRACR2AORAI1
SCHEMBL30677047 0.86 LMNA (0.36) ORAI1
SCHEMBL30677114 0.85 PRKCQ (0.41) CRACR2A
SCHEMBL30677026 0.81 CRACR2A (0.40) CRACR2AORAI1
SCHEMBL30677066 0.79 CRACR2A (0.45) CRACR2APDE10A
SCHEMBL18865624 0.76 SMN1; SMN2 (0.46) —
SCHEMBL22122029 0.76 STIM1 (0.46) ORAI1
SCHEMBL30677244 0.75 CRACR2A (0.43) CRACR2AORAI1
SCHEMBL30677050 0.75 CRACR2A (0.45) CRACR2AORAI1
SCHEMBL30677014 0.74 TRPV1 (0.38) ORAI1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543890-A1 USP1 INHIBITORS AND USES THEREOF Forma Therapeutics, Inc. (US) 2025-04-30 — — EP disclosed
CN-119731178-A USP1 inhibitors and uses thereof 福马治疗有限公司 2025-03-28 — — CN disclosed
WO-2023250084-A1 USP1 INHIBITORS AND USES THEREOF FORMA THERAPEUTICS, INC. (US) 2023-12-28 — — WO disclosed
Send feedback